YHN Acquisition I Limited Announces Pricing of $60,000,000 Initial Public Offering
New York, NY, Sept. 17, 2024 (GLOBE NEWSWIRE) -- YHN Acquisition I Limited (the “Company”) announced today that it priced its initial public offering of 6,000,000 units at $10.00 per…
DarkPulse, Inc. Completes Acquisition of Certain Assets of Optilan UK Ltd Including India and Turkey Subsidiaries
HOUSTON, Sept. 17, 2024 (GLOBE NEWSWIRE) -- DarkPulse, Inc. (OTC: DPLS) (“DarkPulse”, “DPLS", or "the Company") today announced the closing of the acquisition of certain assets of Optilan UK Ltd…
Resolute Holdings Completes Acquisition of Majority Interest in CompoSecure
NEW YORK and SOMERSET, N.J., Sept. 17, 2024 (GLOBE NEWSWIRE) -- Resolute Holdings I, LP and its affiliated vehicles (“Resolute”), an investment firm under the leadership of David Cote and…
Altamira Therapeutics Announces Pricing of up to $12.0 Million Public Offering
Hamilton, Bermuda, Sept. 17, 2024 (GLOBE NEWSWIRE) -- $4 million upfront with up to an additional $8 million of aggregate gross proceeds upon the exercise in full for cash of…
Form 8.3 – [ECKOH PLC – 13 09 2024]
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a)…
Form 8.3 – [KEYWORDS STUDIOS PLC – 13 09 2024]
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a)…
ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences
PRINCETON, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (“ANI” or the “Company”) announced today that the Company has initiated closing logistics for the previously announced…
Theratechnologies Announces a Risk of a Temporary Supply Disruption for EGRIFTA SV® in Early 2025
MONTREAL, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today…
Theratechnologies annonce un risque d’interruption temporaire de l’approvisionnement d’EGRIFTA SVᴹᴰ au début de 2025
MONTRÉAL, 17 sept. 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une entreprise biopharmaceutique axée sur la mise…
Becky G and Vita Coco Build New Greenspace in Inglewood, California
INGLEWOOD, Calif., Sept. 17, 2024 (GLOBE NEWSWIRE) -- As back to school season ramps up, The Vita Coco Company, Inc. (NASDAQ: COCO) has teamed up with international recording artist, actress,…